Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23)Melissa McCracken, Andrew Walkty, Heather J Adam, et al.
Antimicrobial Agents and Chemotherapy|December 2, 2009
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006Heather J Adam, Lisa Louie, Christine Watt, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 studyMelissa G McCracken, Heather J Adam, Joseph M Blondeau, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005Heather J Adam, Kristen N Schurek, Kimberly A Nichol, et al.
The Journal of Antimicrobial Chemotherapy|May 2, 2023
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020Heather J Adam, James A Karlowsky, Melanie R Baxter, et al.
The Journal of Antimicrobial Chemotherapy|April 16, 2020
Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017James A Karlowsky, Heather J Adam, Melanie R Baxter, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
In vitro activity of ceftazidime-avibactam against 338 molecularly characterized gentamicin-nonsusceptible Gram-negative clinical isolates obtained from patients in Canadian hospitalsAndrew J Denisuik, James A Karlowsky, Tyler Denisuik, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 studyGeorge G Zhanel, Heather J Adam, Donald E Low, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance studyJames A Karlowsky, Philippe R S Lagacé-Wiens, Patricia J Simner, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2021
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18James A Karlowsky, Andrew Walkty, Alyssa R Golden, et al.
Pageof 10